Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms (GEP- NENs) - A systematic review and meta-analysis

被引：0
|
作者：
Yu, F. H. [1 ]
Cheng, Z. X. [1 ]
Su, F. [2 ]
Chen, Y. Y. [1 ]
Tan, H. Y. [2 ]
机构：
[1] Beijing Univ Chinese Med, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
gastroenteropancreatic neuroendocrine neoplasm; inflammation-related biomarker; prognostic value;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F25
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [1] Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Cui, Ling-Jun
    Yu, Fu-Huan
    Cheng, Zi-Xuan
    Su, Fei
    Chen, Ying-Ying
    Tan, Huang-Ying
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (04)
  • [2] Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Broadbent, Rachel
    Wheatley, Roseanna
    Stajer, Sabrina
    Jacobs, Timothy
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Amir, Eitan
    McNamara, Mairead G.
    CANCER TREATMENT REVIEWS, 2021, 101
  • [3] Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Broadbent, R.
    Wheatley, R.
    Stajer, S.
    Jacobs, T.
    Lamarca, A.
    Hubner, R.
    Valle, J.
    Amir, E.
    McNamara, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S114 - S114
  • [4] Characteristics, Treatments and Inflammatory Biomarkers in Patients (pts) with G3 Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs)
    Cameselle-Garcia, S.
    Sardo, E.
    Landolfi, S.
    Merino-Casabiel, X.
    Sanchez, J. L.
    Balsells, J.
    Pando, E.
    Blanco, L.
    Diez, M.
    Acosta, D.
    Capdevila, J.
    Hernando, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 64 - 64
  • [5] Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (02) : 295 - 305
  • [6] Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
    Omar Abdel-Rahman
    Mona Fouad
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 295 - 305
  • [7] Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Yan, Yu
    Wu, Danzhu
    Wang, Weizhen
    Lv, Yajuan
    Yang, Liyuan
    Liu, Yinglong
    Dong, Peng
    Yu, Xinshuang
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 633 - 641
  • [8] Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): An updated systematic review of population-based reports from 2010 to 2023
    Nordstrand, Magnus Andreas
    Lea, Dordi
    Soreide, Jon Arne
    JOURNAL OF NEUROENDOCRINOLOGY, 2025, 37 (04)
  • [9] Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis
    Ziogas, Ioannis A.
    Tasoudis, Panagiotis T.
    Borbon, Luis C.
    Sherman, Scott K.
    Breheny, Patrick J.
    Chandrasekharan, Chandrikha
    Dillon, Joseph S.
    Bellizzi, Andrew M.
    Howe, James R.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 148 - 160
  • [10] Health-related quality of life and treatment effects in patients with well-differentiated gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Ronde, Elsa M.
    Heidsma, Charlotte M.
    Eskes, Anne M.
    Schopman, Josefine E.
    van Dijkum, Elisabeth J. M. Nieveen
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (06)
12345